Climaco John M has filed 8 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 9761 shares of CNS Pharmaceuticals, Inc. ($CNSP) on November 17, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 17, 2025 | CNS Pharmaceuticals, Inc. | $CNSP | Climaco John M | Chief Executive Officer | A | Option to purchase common stock | 9761 | $0.00 | 9,761.0000 | 620,290 | 9999.99% | 1.57% |
| Nov. 12, 2025 | Moleculin Biotech, Inc. | $MBRX | Climaco John M | Director | A | Stock Options (right to buy) | 150000 | $0.00 | 165,169.0000 | 50,910,476 | 988.86% | 0.29% |
| Nov. 4, 2024 | Moleculin Biotech, Inc. | $MBRX | Climaco John M | Director | A | Stock option (right to buy) | 10000 | $0.00 | 15,169.0000 | 0 | 193.46% | 0.00% |
| April 8, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Climaco John M | Chief Executive Officer | A | Option to purchase common stock | 83000 | $0.00 | 476,533.0000 | 0 | 21.09% | 0.00% |
| April 8, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Climaco John M | Chief Executive Officer | A | Restricted Stock Units | 83000 | $0.00 | 559,533.0000 | 0 | 17.42% | 0.00% |
| Feb. 1, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Climaco John M | Chief Executive Officer | A | Series B Warrant to purchase common stock | 166666 | $0.00 | 393,533.0000 | 0 | 73.46% | 0.00% |
| Feb. 1, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Climaco John M | Chief Executive Officer | A | Series A Warrant to purchase common stock | 166666 | $0.00 | 226,867.0000 | 0 | 276.85% | 0.00% |
| Feb. 1, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Climaco John M | Chief Executive Officer | P | Common stock | 166666 | $0.30 | 215,676.0000 | 0 | 340.07% | 0.00% |